The Role of RIPK1 and RIPK3 in Cardiovascular Disease

Area of Science:

• Cardiovascular Science
• Cell Death Research
• Molecular Biology

Background:

• Cardiovascular diseases are the leading global cause of mortality.
• Necroptosis, a regulated form of necrotic cell death, is increasingly implicated in cardiovascular pathology.
• Receptor Interacting Protein Kinase 1 (RIPK1) and Receptor Interacting Protein Kinase 3 (RIPK3) are key mediators of necroptosis.

Purpose of the Study:

• To review the current evidence linking RIPK1 and RIPK3 to cardiovascular disease.
• To highlight the therapeutic potential of RIPK1 and RIPK3 inhibitors in cardiovascular conditions.

Main Methods:

• Literature review of studies investigating necroptosis in cardiovascular disease.
• Analysis of research on the roles of RIPK1 and RIPK3 in cardiovascular pathology.
• Examination of preclinical and clinical data on RIPK1 and RIPK3 inhibitors.

Main Results:

• Evidence supports a significant pathological role for RIPK1 and RIPK3 in cardiovascular diseases such as myocardial infarction and stroke.
• Targeted inhibition of RIPK1 and RIPK3 has demonstrated efficacy in preclinical models.
• RIPK1 and RIPK3 inhibitors represent a promising therapeutic strategy for cardiovascular disease.

Conclusions:

• RIPK1 and RIPK3 are critical mediators of cell death in cardiovascular disease.
• Targeting RIPK1 and RIPK3 offers a novel therapeutic avenue for cardiovascular disease prevention and treatment.